share_log

HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target

Benzinga ·  Oct 7 17:35  · Ratings

HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment